Burke MC, Mirokhin YA, Tchekhovskoi DV, Markey SP, Heidbrink Thompson J, Larkin C, et al
10.1016/j.phrs.2008.09.003 57 LeeW
heart failure risk - An FDA warning (4/6/16) was added to saxagliptin regarding an increased risk of heart failure observed in two randomized trials (3.5% risk vs 2.8% for those taking placebo)
Specific safety concerns warrant attention in certain populations
Visible Specks or Floaters: Any solid particles, no matter how small, mean your solution is contaminated or the peptide has degraded
Studies focus on how Cagrilintide modulates alpha cell activity during postprandial states to reduce inappropriate glucagon secretion, helping to maintain homeostatic hepatic glucose output under experimental conditions